128 related articles for article (PubMed ID: 33374094)
41. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
42. Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps.
Kamecke U; Waldenmaier D; Haug C; Ziegler R; Freckmann G
J Diabetes Sci Technol; 2019 Jan; 13(1):60-67. PubMed ID: 30003823
[TBL] [Abstract][Full Text] [Related]
43. [Insulin pump therapy in children, adolescents and adults, guidelines (Update 2019)].
Schütz-Fuhrmann I; Stadler M; Zlamal-Fortunat S; Rami-Merhar B; Fröhlich-Reiterer E; Hofer SE; Mader J; Resl M; Bischof M; Kautzky-Willer A; Weitgasser R
Wien Klin Wochenschr; 2019 May; 131(Suppl 1):47-53. PubMed ID: 30980146
[TBL] [Abstract][Full Text] [Related]
44. Disparities in Insulin Pump Therapy Persist in Youth With Type 1 Diabetes Despite Rising Overall Pump Use Rates.
O'Connor MR; Carlin K; Coker T; Zierler B; Pihoker C
J Pediatr Nurs; 2019; 44():16-21. PubMed ID: 30581163
[TBL] [Abstract][Full Text] [Related]
45. Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes.
Mathiesen JM; Secher AL; Ringholm L; Nørgaard K; Hommel E; Andersen HU; Damm P; Mathiesen ER
J Matern Fetal Neonatal Med; 2014 May; 27(7):724-8. PubMed ID: 23981186
[TBL] [Abstract][Full Text] [Related]
46. Air occlusion in insulin pumps of children and adolescents with type 1 diabetes.
Knoll MM; Vazifedan T; Gyuricsko E
J Pediatr Endocrinol Metab; 2020 Feb; 33(2):179-184. PubMed ID: 31812947
[TBL] [Abstract][Full Text] [Related]
47. Insulin pump dosing across gestation in women with well-controlled type 1 diabetes mellitus.
Roeder HA; Moore TR; Ramos GA
Am J Obstet Gynecol; 2012 Oct; 207(4):324.e1-5. PubMed ID: 23021699
[TBL] [Abstract][Full Text] [Related]
48. Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients.
Kapellen TM; Klinkert C; Heidtmann B; Jakisch B; Haberland H; Hofer SE; Holl RW
Postgrad Med; 2010 May; 122(3):98-105. PubMed ID: 20463419
[TBL] [Abstract][Full Text] [Related]
49. Relationship between Basal insulin requirement and body mass index in children and adults with type 1 diabetes on insulin pump therapy.
Deeb A; Abu-Awad S; Tomy M; Suliman S; Mustafa H
J Diabetes Sci Technol; 2015 May; 9(3):711-2. PubMed ID: 25691654
[No Abstract] [Full Text] [Related]
50. Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.
Sherr JL; Palau Collazo M; Cengiz E; Michaud C; Carria L; Steffen AT; Weyman K; Zgorski M; Tichy E; Tamborlane WV; Weinzimer SA
Diabetes Care; 2014; 37(3):773-9. PubMed ID: 24170766
[TBL] [Abstract][Full Text] [Related]
51. Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty.
Cemeroglu AP; Thomas JP; Zande LT; Nguyen NT; Wood MA; Kleis L; Davis AT
Endocr Pract; 2013; 19(5):805-11. PubMed ID: 23757622
[TBL] [Abstract][Full Text] [Related]
52. Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus.
Laimer M; Melmer A; Mader JK; Schütz-Fuhrmann I; Engels HR; Götz G; Pfeifer M; Hermann JM; Stettler C; Holl RW
PLoS One; 2016; 11(3):e0150604. PubMed ID: 26938444
[TBL] [Abstract][Full Text] [Related]
53. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
[TBL] [Abstract][Full Text] [Related]
54. Rediscovery of insulin pump treatment of childhood type 1 diabetes.
Weinzimer SA; Doyle EA; Steffen AT; Sikes KA; Tamborlane WV
Minerva Med; 2004 Apr; 95(2):85-92. PubMed ID: 15272243
[TBL] [Abstract][Full Text] [Related]
55. A novel adaptive basal therapy based on the value and rate of change of blood glucose.
Wang Y; Percival MW; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
J Diabetes Sci Technol; 2009 Sep; 3(5):1099-108. PubMed ID: 20144423
[TBL] [Abstract][Full Text] [Related]
56. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
[TBL] [Abstract][Full Text] [Related]
57. Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: A 1-year prospective observational study with suggestions to minimize clinical impact.
Rabbone I; Minuto N; Toni S; Lombardo F; Iafusco D; Marigliano M; Schiaffini R; Maltoni G; Frongia AP; Scardapane M; Nicolucci A; Cherubini V; Bonfanti R; Scaramuzza AE;
Diabetes Obes Metab; 2018 Nov; 20(11):2551-2556. PubMed ID: 29893044
[TBL] [Abstract][Full Text] [Related]
58. What is the best way to deliver subcutaneous insulin to infants, children, and young people with type 1 diabetes mellitus?
Blair JC; Peak M; Gregory JW
BMJ; 2011 Sep; 343():d5221. PubMed ID: 21890564
[No Abstract] [Full Text] [Related]
59. Demographic and regional disparities in insulin pump utilization in a setting of universal funding: a New Zealand nationwide study.
McKergow E; Parkin L; Barson DJ; Sharples KJ; Wheeler BJ
Acta Diabetol; 2017 Jan; 54(1):63-71. PubMed ID: 27650535
[TBL] [Abstract][Full Text] [Related]
60. Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience.
Matejko B; Kukułka A; Kieć-Wilk B; Stąpór A; Klupa T; Malecki MT
Adv Med; 2018; 2018():1473160. PubMed ID: 29974056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
